Leukemia, Myelomonocytic, Acute
"Leukemia, Myelomonocytic, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. At least 20% of non-erythroid cells are of monocytic origin.
| Descriptor ID |
D015479
|
| MeSH Number(s) |
C04.557.337.539.520
|
| Concept/Terms |
Leukemia, Myelomonocytic, Acute- Leukemia, Myelomonocytic, Acute
- Leukemia, Myeloid, Naegeli-Type
- Myeloid Leukemia, Naegeli-Type
- Leukemia, Naegeli-Type Myeloid
- Myeloid Leukemia, Naegeli Type
- Naegeli-Type Myeloid Leukemia
- Myelomonocytic Leukemia, Acute
- Acute Myelomonocytic Leukemia
- Acute Myelomonocytic Leukemias
- Leukemia, Acute Myelomonocytic
- Leukemias, Acute Myelomonocytic
- Myelomonocytic Leukemias, Acute
- Leukemia, Myeloid, Acute, M4
- Myeloid Leukemia, Acute, M4
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Myelomonocytic, Acute".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Myelomonocytic, Acute".
This graph shows the total number of publications written about "Leukemia, Myelomonocytic, Acute" by people in this website by year, and whether "Leukemia, Myelomonocytic, Acute" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 3 | 1 | 4 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 3 | 0 | 3 |
| 2014 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Myelomonocytic, Acute" by people in Profiles.
-
Incidence of tumor lysis syndrome in patients with acute myeloid leukemia undergoing low-intensity induction with venetoclax. Am J Hematol. 2021 03 01; 96(3):E65-E68.
-
Current and emerging therapies for patients with acute myeloid leukemia: a focus on MCL-1 and the CDK9 pathway. Am J Manag Care. 2018 08; 24(16 Suppl):S356-S365.
-
Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal. Ann Oncol. 2014 Sep; 25(9):1691-1700.
-
Interaction between myelomonocytic and lymphoid cells in a patient with acute myelomonocytic leukemia and chronic lymphocytic leukemia. Leuk Lymphoma. 2014 Jun; 55(6):1425-7.
-
Deletion of TAK1 in the myeloid lineage results in the spontaneous development of myelomonocytic leukemia in mice. PLoS One. 2012; 7(12):e51228.
-
The organic arsenic derivative GMZ27 induces PML-RARa-independent apoptosis in myeloid leukemia cells. Anticancer Res. 2012 Jul; 32(7):2871-80.
-
The value of immunohistochemistry for CD14, CD123, CD33, myeloperoxidase and CD68R in the diagnosis of acute and chronic myelomonocytic leukaemias. Histopathology. 2012 May; 60(6):933-42.
-
Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemia. Am J Hematol. 2012 Mar; 87(3):317-8.
-
Acute myeloid leukemia with t(9;11)(p21-22;q23): common properties of dysregulated ras pathway signaling and genomic progression characterize de novo and therapy-related cases. Am J Clin Pathol. 2010 May; 133(5):686-93.
-
Comparative analysis of genes regulated in acute myelomonocytic leukemia with and without inv(16)(p13q22) using microarray techniques, real-time PCR, immunohistochemistry, and flow cytometry immunophenotyping. Mod Pathol. 2007 Aug; 20(8):811-20.